or Try an Advanced Search...

    ETF Components for EUDV - ProShares MSCI Europe Dividend Growers ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    DEO F 1.69 2.35
    NVS D 0.41 2.22

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Alcohol Alcoholic Drinks Animal Health Antibiotics Beer Biotechnology Blood Test Canadian Whisky Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Distilled Drinks Drink Drugs Eye Eye Care Eye Care Products
    Industries: Beverages - Wineries & Distilleries Drug Manufacturers - Major

    Recent News for ProShares MSCI Europe Dividend Growers ETF & its Holdings

    Date Stock Title
    Nov 22 NVS Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
    Nov 22 NVS Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
    Nov 22 DEO Drinks M&A recovery set to continue in 2025
    Nov 22 NVS Novartis provides updates to mid-term guidance, now sees 6% sales CAGR 2023-2028
    Nov 22 NVS Novartis acquires Kate Therapeutics to advance gene therapies
    Nov 21 DEO CROWN ROYAL JOINS FORCES WITH NATE SMITH AND SCOTTY HASTING TO SUPPORT VETERANS AS THE AWARD-WINNING WHISKY DONATES $50,000 TO CREATIVETS ON COUNTRY MUSIC'S BIGGEST NIGHT
    Nov 21 DEO Major companies that are also popular short-selling stocks
    Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
    Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
    Nov 21 DEO Captain Morgan Ventures into Fresh Territory with Super Bowl Champion Victor Cruz and KidSuper for the Most Adventurous Collab of the Season
    Nov 21 DEO JOHNNIE WALKER RENEWS SUCCESSFUL LUNAR NEW YEAR PARTNERSHIP WITH VISIONARY ARTIST JAMES JEAN
    Nov 21 DEO Diageo “to pause” Crown Royal distillery construction in Canada
    Nov 21 NVS Novartis raises mid-term sales guidance
    Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
    Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
    Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
    Nov 20 DEO DELEÓN Tequila Unveils Its New Campaign and Brand Platform, "Bold Spirits, Rise"
    Nov 19 DEO Diageo: No Path For Market-Beating Returns
    Nov 19 DEO Casa Redondo eyes “more muscle” with M&A on back of Safari “party drink” purchase – CEO Daniel Redondo
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    The investment seeks investment results, before fees and expenses, that track the performance of the MSCI Europe Dividend Masters Index (the "index"). The fund will invest at least 80% of its total assets in component securities (i.e., securities of the index and comparable securities that have economic characteristics that are substantially identical to the economic characteristics of the securities of the index). The index, constructed and maintained by MSCI, targets companies that are currently members of the MSCI Europe Index ("MSCI Europe") and have increased dividend payments each year for at least 10 years.
    Exchange Traded Fund ETF
    Back to the Main EUDV Page...